Normal and cancer cell metabolism: lymphocytes and lymphoma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  The FEBS Journal

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1742-4658.2012.08651.xPMID 22672505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid metabolism in cancer.

  2013cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Lipid metabolism in cancer

  2012cited by this paper
• Amino acid sensing mechanisms: an Achilles heel in cancer?

  2012cited by this paper
• Metformin and neoplasia: implications and indications.

  2012cited by this paper
• Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells.

  2012cited by this paper
• Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets

  2011cited by this paper
• The descent of memory T cells

  2011cited by this paper
• Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells.

  2011cited by this paper
• Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation

  2011cited by this paper
• Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate

  2011cited by this paper
• Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.

  2011cited by this paper
• Endogenous Myc maintains the tumor microenvironment.

  2011cited by this paper
• MYC and Aggressive B-cell Lymphomas

  2011cited by this paper
• mTOR links oncogenic signaling to tumor cell metabolism

  2011cited by this paper
• Resistance to HER2-directed antibodies and tyrosine kinase inhibitors

  2011cited by this paper
• Therapeutic targeting of Myc-reprogrammed cancer cell metabolism.

  2011cited by this paper
• The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

  2011cited by this paper
• Myc proteins as therapeutic targets

  2010cited by this paper
• Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

  2010cited by this paper
• AMP-activated protein kinase and its downstream transcriptional pathways

  2010cited by this paper
• Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

  2010cited by this paper
• Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.

  2010cited by this paper
• The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.

  2010cited by this paper
• IL-7 Is Essential for Homeostatic Control of T Cell Metabolism In Vivo

  2010cited by this paper
• The metabolic life and times of a T‐cell

  2010cited by this paper
• Metabolic Modulation of Glioblastoma with Dichloroacetate

  2010cited by this paper
• The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism.

  2010cited by this paper
• Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells*

  2010cited by this paper
• Glutamine addiction: a new therapeutic target in cancer.

  2010cited by this paper
• Triple-negative breast cancer.

  2010cited by this paper
• Enhancing CD8 T-cell memory by modulating fatty acid metabolism

  2009cited by this paper
• Signaling networks associated with BCR-ABL-dependent transformation.

  2009cited by this paper
• New Users of Metformin Are at Low Risk of Incident Cancer

  2009cited by this paper
• Abstract #LB-186: c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism

  2009cited by this paper
• c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism

  2009cited by this paper
• Nampt: linking NAD biology, metabolism and cancer.

  2009cited by this paper
• mTOR regulates memory CD8 T cell differentiation

  2009cited by this paper
• Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate

  2009cited by this paper
• Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

  2009cited by this paper
• Naive T cell homeostasis: from awareness of space to a sense of place

  2009cited by this paper
• Biological determinants of endocrine resistance in breast cancer

  2009cited by this paper
• The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies.

  2009cited by this paper
• Glucose deprivation-induced metabolic oxidative stress and cancer therapy.

  2009cited by this paper
• Estrogen-related receptor-α antagonist inhibits both estrogen receptor–positive and estrogen receptor–negative breast tumor growth in mouse xenografts

  2009cited by this paper
• MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities

  2009cited by this paper
• ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation

  2009cited by this paper
• Modelling Myc inhibition as a cancer therapy

  2008cited by this paper
• Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia

  2008cited by this paper
• It's T-ALL about Notch

  2008cited by this paper
• The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

  2008cited by this paper
• Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer.

  2008cited by this paper
• New roles for pyruvate kinase M2: working out the Warburg effect.

  2008cited by this paper
• IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival.

  2008cited by this paper
• Triple-negative breast cancer.

  2008cited by this paper
• Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

  2008cited by this paper
• Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation*

  2008cited by this paper
• Pyruvate kinase M2 is a phosphotyrosine-binding protein

  2008cited by this paper
• Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways1

  2008cited by this paper
• A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

  2007cited by this paper
• Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets

  2007cited by this paper
• Biology and treatment of Burkitt's lymphoma

  2007cited by this paper
• Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

  2007cited by this paper
• Pathways to tamoxifen resistance.

  2007cited by this paper
• Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking.

  2007cited by this paper
• Trastuzumab--mechanism of action and use in clinical practice.

  2007cited by this paper
• Regulation of lymphocyte development by Notch signaling

  2007cited by this paper
• Life and death in peripheral T cells

  2007cited by this paper
• Coping with stress: multiple ways to activate p53

  2007cited by this paper
• Asymmetric T Lymphocyte Division in the Initiation of Adaptive Immune Responses

  2007cited by this paper
• Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1.

  2007cited by this paper
• NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth

  2006cited by this paper
• Notch1 Contributes to Mouse T-Cell Leukemia by Directly Inducing the Expression of c-myc

  2006cited by this paper
• Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells.

  2006cited by this paper
• FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal

  2006cited by this paper
• The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

  2006cited by this paper
• Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.

  2006cited by this paper
• Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt

  2006cited by this paper
• c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.

  2006cited by this paper
• HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

  2006cited by this paper
• Evidence That Ser87 of BimEL Is Phosphorylated by Akt and Regulates BimEL Apoptotic Function*

  2006cited by this paper
• Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer

  2006cited by this paper
• Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.

  2006cited by this paper
• Metformin and reduced risk of cancer in diabetic patients

  2005cited by this paper
• Signal transducer and activator of transcription 5 (STAT5), a crucial regulator of immune and cancer cells.

  2005cited by this paper
• A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) study

  2005cited by this paper
• Putting the rap on Akt.

  2004cited by this paper
• STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5.

  2004cited by this paper
• Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.

  2004cited by this paper
• Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer.

  2004cited by this paper
• Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.

  2004cited by this paper
• Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia

  2004cited by this paper
• 2-Deoxy-d-glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers In Vivo

  2004cited by this paper
• Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma

  2003cited by this paper
• Targeting RAS signalling pathways in cancer therapy

  2003cited by this paper
• The Bcl-2 family: roles in cell survival and oncogenesis

  2003cited by this paper
• Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival

  2003cited by this paper
• FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.

  2003cited by this paper

• Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics

  2025cites this paper
• Performance of Raman Spectroscopy in biopsy tissue for rapid diagnosis of Tracheobronchial Tuberculosis: a prospective study.

  2025cites this paper
• A new approach for automatic classification of non-Hodgkin lymphoma using deep learning and classical learning methods on histopathological images

  2024influential citation
• Towards a framework for predicting immunotherapy outcome: a hybrid multiscale mathematical model of immune response to vascular tumor growth

  2024cites this paper
• Automatic subtyping of Diffuse Large B-cell Lymphomas (DLBCL): Raman-based genetic and metabolic classification.

  2023cites this paper
• Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment

  2023influential citation
• Prediction of the postoperative prognosis in patients with non-muscle-invasive bladder cancer based on preoperative serum surface-enhanced Raman spectroscopy.

  2022cites this paper
• Mapping CAR T-Cell Design Space Using Agent-Based Models

  2022influential citation
• Cancer-Related Malnutrition: Epidemiological Results from the Latin American Study of Malnutrition in the Oncology Practice

  2021cites this paper
• Natural Compounds as Metabolic Modulators of the Tumor Microenvironment

  2021cites this paper
• Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas

  2021cites this paper
• Identification of lncRNA Signature Associated With Pan-Cancer Prognosis

  2020cites this paper
• Oncogenic Mechanisms and Therapeutic Targeting of Metabolism in Leukemia and Lymphoma.

  2020cites this paper
• Clinical Significance of Plasma Levels of Gluconeogenic Amino Acids in Esophageal Cancer Patients

  2020cites this paper
• Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy.

  2019cites this paper
• Mitochondrial Retrograde Signalling and Metabolic Alterations in the Tumour Microenvironment

  2019cites this paper
• Activation of T and B lymphocytes Induces Increased Uptake of Poly-Dispersed Single-Walled Carbon Nanotubes and Enhanced Cytotoxicity

  2019cites this paper
• Glutamine/glutamate metabolism rewiring in reprogrammed human hepatocyte-like cells

  2019cites this paper
• Identifying non-muscle-invasive and muscle-invasive bladder cancer based on blood serum surface-enhanced Raman spectroscopy.

  2019cites this paper
• Metabolic regulation of macrophages in tumor microenvironment

  2018cites this paper
• Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease

  2018cites this paper
• Influence of dietary fats on circulating amino acid profile in experimental breast cancer

  2018cites this paper
• Metabolic Stress in the Immune Function of T Cells, Macrophages and Dendritic Cells

  2018cites this paper
• Impact of an anti-metabolic therapy on leukemic and non-malignant T cells

  2018cites this paper
• Aging, Metabolism, and Cancer Development: from Peto’s Paradox to the Warburg Effect

  2017cites this paper
• Enhancement of Lytic Activity by Leptin Is Independent From Lipid Rafts in Murine Primary Splenocytes

  2017cites this paper
• The c-Rel Transcription Factor Controls Metabolism and Proliferation of Human T Cells

  2017cites this paper
• MYC and HIF in shaping immune response and immune metabolism.

  2017cites this paper
• Impairment of mitochondrial respiratory function as an early biomarker of apoptosis induced by growth factor removal

  2017cites this paper
• ROS homeostasis and metabolism: a critical liaison for cancer therapy

  2016cites this paper
• Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis

  2016cites this paper
• Taurine Attenuates Dimethylbenz[a]anthracene-induced Breast Tumorigenesis in Rats: A Plasma Metabolomic Study.

  2016cites this paper
• Hodgkin and Reed–Sternberg cells of classical Hodgkin lymphoma are highly dependent on oxidative phosphorylation

  2016cites this paper
• Metabolically Relevant Cell Biology – Role of Intracellular Organelles for Cardiac Metabolism

  2016cites this paper
• Synergism of IL10R and TLR9 signaling affects gene expression, proliferation and metabolism in B cells: A comparative study of STAT3/NF-kB and c-Myc mediated effects

  2016cites this paper
• Cellular Energy Metabolism in T-Lymphocytes

  2015cites this paper
• The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis.

  2015cites this paper
• Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

  2015cites this paper
• Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells

  2015cites this paper
• Evidence of cancer‐promoting roles for AMPK and related kinases

  2015cites this paper
• Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2‐deoxy‐glucose affects effector functions

  2015cites this paper
• Regulation of rDNA transcription in response to growth factors, nutrients and energy.

  2015cites this paper
• Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells

  2015cites this paper
• Perioperative dynamics and significance of amino acid profiles in patients with cancer

  2015cites this paper
• UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL SCHOOL PHD THESIS – ABSTRACT – ROLE OF RADIO-IMAGING EXAMINATION IN DIAGNOSIS AND EVALUATION OF BONE DETERMINATIONS IN MALIGNANT HEMOPATHIES

  2015cites this paper
• Is cancer a metabolic disease?

  2014influential citation
• Preface: oncometabolism: a new field of research with profound therapeutic implications.

  2014cites this paper
• Small Molecule Therapeutics AntitumorActivity of 7-AminocarboxycoumarinDerivatives , a NewClass of Potent Inhibitors of Lactate In fl ux but Not Ef fl ux

  2014cites this paper
• Preface: oncometabolism: a new field of research with profound therapeutic implications.

  2014cites this paper
• Antitumor Activity of 7-Aminocarboxycoumarin Derivatives, a New Class of Potent Inhibitors of Lactate Influx but Not Efflux

  2014cites this paper
• Targeting Cell Metabolism in Chronic Lymphocytic Leukaemia (cll); Aviable Therapeutic Approach?

  2014cites this paper
• Cancer Metabolism: A Nexus of Matter, Energy, and Reactive Oxygen Species

  2014cites this paper
• Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy.

  2014cites this paper
• Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders

  2014cites this paper
• Lessons from patient-derived xenografts for better in vitro modeling of human cancer.

  2014cites this paper
• Clinical analysis of stages of HBV infection in 100 cases of lymphoma.

  2013cites this paper
• Autophagy and cellular immune responses.

  2013cites this paper
• Isoform identification and partial characterisation of Glutaminase in CD4+ T lymphocytes

  2013cites this paper
• Znaczenie metabolizmu glukozy w diagnostyce oraz terapii nowotworów układów krwiotwórczego i chłonnego

  2013cites this paper
• Plasma-free amino acid profiling of cervical cancer and cervical intraepithelial neoplasia patients and its application for early detection

  2013cites this paper
• Metabolic regulation of T lymphocytes.

  2013cites this paper
• Metabolic targets for cancer therapy

  2013cites this paper
• Matched and mismatched metabolic fuels in lymphocyte function.

  2012cites this paper
• Amino acid sensing mechanisms: an Achilles heel in cancer?

  2012cites this paper
• How cancer metabolism is tuned for proliferation and vulnerable to disruption

  2012cites this paper